Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells (Q28550076)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells |
scientific article |
Statements
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells (English)
0 references
Andreas Lundqvist
Andreas
Lundqvist
1 reference
Barbara Seliger
Barbara
Seliger
1 reference
Riki Okita
1 reference
Diana Wolf
1 reference
Koichiro Yasuda
1 reference
Ai Maeda
1 reference
Takuro Yukawa
1 reference
Shinsuke Saisho
1 reference
Katsuhiko Shimizu
1 reference
Yoshiyuki Yamaguchi
1 reference
Mikio Oka
1 reference
Eiichi Nakayama
1 reference
Rolf Kiessling
1 reference
Masao Nakata
1 reference
2015
0 references
10
0 references
10
0 references
e0139809
0 references
6 October 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference